Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism NCL inhibitors(Nucleolin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC34H41NO4 |
InChIKeyUKJXAQYJWFBJPH-HUZMGXJZSA-N |
CAS Registry- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Triple Negative Breast Cancer | Preclinical | China | 16 Jun 2026 |





